Kalle E Mattila (Kalle Mattila)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Advanced Cancer

Systematic Review

Ejection Fraction

Top Venues

Acta oncologica (Stockholm, Sweden)

Journal of clinical medicine

Therapeutic advances in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Saana Virtanen, Heidi Pihlman, Maria Silvoniemi, Pia P Vihinen, Panu M Jaakkola, Kalle E Mattila
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study. Cancers 16 (4) (2024)
Saana Virtanen, Heidi Pihlman, Maria Silvoniemi, Pia P Vihinen, Panu M Jaakkola, Kalle E Mattila
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study. Cancers 16 (4) (2024)
Olivia Hölsä, Kaisa Teittinen, Anna Anttalainen, Liisa Ukkola-Vuoti, Milla Summanen, Kalle E Mattila
Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021. Therapeutic advances in urology 15 (2023)
Kalle E Mattila, Siru Mäkelä, Soili Kytölä, Emma Andersson, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Kristiina Aittomäki, Micaela Hernberg
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta oncologica (Stockholm, Sweden) 61 (10) (2022)
Kalle E Mattila, Paula Vainio, Panu M Jaakkola
Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy. Cancers 14 (1) (2022)
Nieves Martínez Campayo, Sabela Paradela de la Morena, Sonia Pértega-Díaz, Luisa Iglesias Pena, Pia P Vihinen, Kalle E Mattila, Marko B Lens, Antonio Tejera-Vaquerizo, Eduardo Fonseca
Survival of Women Previously Diagnosed of Melanoma with Subsequent Pregnancy: A Systematic Review and Meta-Analysis and a Single-Center Experience. Journal of clinical medicine 11 (1) (2021)
Kalle E Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Siru Mäkelä, Micaela M Hernberg
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma. Acta oncologica (Stockholm, Sweden) 59 (3) (2019)